DeepTech Investor Summit

Tandem Therapeutics AG

ETH spin-off

tandem-tx.comZurich, Switzerland
8 profile visits

About

TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approach to fibrosis and fibrotic cancers. As a ETH Zürich and Paul Scherrer Institute Spin-off, we advance transformative research and development in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic diseases.

Social media

Target Markets of your organization / Expansion or target markets of your spin-off

SwitzerlandUSEMEAAPACGlobal

Industry Sector your organization invests in / Industry Sector of your Spin-off

Bio Tech

Representatives

Co-founder & CEO

Tandem Therapeutics AG